Liron Pantanowitz, MD; Lester D.R. Thompson, MD Mye loid sarcoma (MS) is an ext ramedu llary myeloid tumor (gran ulocytic sarcoma) that ca n occ ur in one of three clinical settings: ( I) in patients who have a history of acute mye loid leukem ia (AM L), durin g active disease or a recur rence; (2) in patients with chro nic mye lopro liferative diso rder or mye lodysplast ic sy ndro mes, who are at increased risk of blast tra nsformation or acute leukemia; or (3) in patient s with no history of hem atologic disease, althoug h it com mon ly predates the development of leukem ia, often wit hin I year.
MS is a localized mass of mye lob lasts with or without addi tional immature myeloid cells. Chloroma (chlor = gree n, oma = tumor) is an old clin ical term that refers to the gree n hue identified in fres h specime ns as a res ult of myeloperoxidase pro duction. This gree n hue is lost with forma lin fixation. In the head and neck regio n, MS has a pro pensity to invo lve the subperiosteal bo nes of the skull, paranasal sinuses, and orbit, as well as the soft tissues of the nasopharynx, lymph nodes, and ski n. It occ urs mos t ofte n in pediatric and you ng adult patients.
MS is made up of a diffuse, fairly monotonous infiltrate of medium -size or large cells with three levels of differentiation: blastic , imma ture, and differentiated (figure):
• The blastic type is made up of myeloblasts with round-to-oval nucl ei, 2 to 4 small nucleoli, fine nuclear chromatin, and a rim of basophilic, finely gra nular cyto plasm (so metimes containingAuer rods) .
• The imm ature type is intermediate, made up of both blast-li ke cells and promye locy tes with variab ly lobated nucl ei.
• Th e differentiated stage is primari ly made up of promyelocytes with eos inophil and neutrophil maturation. Th e presence of imm ature eosi nophil s and neut roph ils usually indica tes the true nature of this les ion (as opposed to a maligna nt lymph oma).
Histochem ical stai ning forc hloroacetate es terase (Leder stain), which stains neutro phils and precurso rs, is usu ally pos itive , although some times on ly focally. Giemsa-stained tou ch pre paration s dem on strate cy toplasmic granules. Immun oh istoch emi cal stai ns (mye loperoxidase, lysozym e, CD 34 , non sp ecific es terase , and C D68), as we ll as flow cytome try, are frequ ently req uired to make a definitive diagnos is.
MS is frequent ly misdiagnosed , especially w hen it precedes a diagnosis of AM L by several months or even years . T he d ifferential diag nosis includes a variety of lymphom as, neurobl astom a, rh abd om yosar com a, and Ew ing sa rco ma or primiti ve neuroectodermal tumo rs. W he n correctly diagnosed, treatm ent is identical to tha t for AM L, with systemic chemotherapy and possible ste m cell tra nsplantation; local rad iatio n is employed in the absence of bo ne marrow involvement. --~.
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